We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.71%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.3B
AUM Growth
-$783M
(-2.3%)
Cap. Flow
-$715M
Cap. Flow
% of AUM
-2.15%
Top 10 Holdings %
Top 10 Hldgs %
15.9%
Holding
3,039
New
28
Increased
1,056
Reduced
1,268
Closed
57
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$29M |
| 2 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$14M |
| 3 |
Microsoft
MSFT
|
+$10.8M |
| 4 |
Meta Platforms (Facebook)
META
|
+$10.5M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$6.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$34.4M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
+$32.2M |
| 3 |
ExxonMobil
XOM
|
+$23.9M |
| 4 |
Warner Bros
WBD
|
+$15.4M |
| 5 |
RTX Corp
RTX
|
+$13.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.81% |
| 2 | Financials | 14.8% |
| 3 | Healthcare | 13.73% |
| 4 | Industrials | 10.72% |
| 5 | Energy | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VTLE
1626
DELISTED
Vital Energy
VTLE
| $1.22M | ﹤0.01% |
2,721
+26
| +1% | +$13.3K |
|
|
EPAY
1627
DELISTED
Bottomline Technologies Inc
EPAY
| $1.22M | ﹤0.01% |
44,097
| – | – |
|
|
HTWR
1628
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $1.22M | ﹤0.01% |
15,671
-640
| -4% | -$53K |
|
1629
Mitsubishi UFJ Financial
MUFG
$254B
| $1.22M | ﹤0.01% |
216,670
| – | – |
|
1630
Dycom Industries
DY
$12.6B
| $1.22M | ﹤0.01% |
39,576
+50
| +0.1% | +$1.52K |
|
1631
St. Joe Company
JOE
$3.62B
| $1.22M | ﹤0.01% |
60,985
-1,230
| -2% | -$27.6K |
|
|
OSG
1632
Octave Specialty Group
OSG
$252M
| $1.21M | ﹤0.01% |
54,936
-940
| -2% | -$22.1K |
|
1633
Credit Acceptance
CACC
$5.97B
| $1.21M | ﹤0.01% |
9,626
-20
| -0.2% | -$2.45K |
|
|
PES
1634
DELISTED
Pioneer Energy Services Corp.
PES
| $1.21M | ﹤0.01% |
86,456
+90
| +0.1% | +$1.41K |
|
1635
EXL Service
EXLS
$5.22B
| $1.21M | ﹤0.01% |
247,660
-500
| -0.2% | -$2.78K |
|
1636
LCI Industries
LCII
$2.51B
| $1.21M | ﹤0.01% |
28,663
+200
| +0.7% | +$9.06K |
|
|
PVA
1637
DELISTED
PENN VIRGINIA CORP
PVA
| $1.21M | ﹤0.01% |
94,869
+2,090
| +2% | +$29.3K |
|
1638
Dorman Products
DORM
$3.78B
| $1.2M | ﹤0.01% |
30,044
+210
| +0.7% | +$9.37K |
|
|
CCC
1639
DELISTED
Calgon Carbon Corp
CCC
| $1.2M | ﹤0.01% |
62,094
+80
| +0.1% | +$1.71K |
|
|
ASCMA
1640
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $1.2M | ﹤0.01% |
19,979
| – | – |
|
|
PMC
1641
DELISTED
PharMerica Corporation
PMC
| $1.2M | ﹤0.01% |
49,122
-130
| -0.3% | -$3.45K |
|
1642
Cohen & Steers
CNS
$4.36B
| $1.2M | ﹤0.01% |
31,202
+12,450
| +66% | +$529K |
|
|
QLGC
1643
DELISTED
QLOGIC CORP
QLGC
| $1.2M | ﹤0.01% |
130,857
+450
| +0.3% | +$4.29K |
|
1644
Standex International
SXI
$3.7B
| $1.2M | ﹤0.01% |
16,131
-340
| -2% | -$24.6K |
|
|
MTOR
1645
DELISTED
MERITOR, Inc.
MTOR
| $1.19M | ﹤0.01% |
109,913
+1,090
| +1% | +$14.2K |
|
1646
MannKind Corp
MNKD
$1.18B
| $1.19M | ﹤0.01% |
40,301
-1,988
| -5% | -$78.4K |
|
|
TYPE
1647
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $1.19M | ﹤0.01% |
42,039
+170
| +0.4% | +$4.96K |
|
1648
iShares Core US Aggregate Bond ETF
AGG
$137B
| $1.19M | ﹤0.01% |
10,904
-37,133
| -77% | -$4.05M |
|
1649
Globalstar
GSAT
$10.9B
| $1.19M | ﹤0.01% |
21,667
+47
| +0.2% | +$2.8K |
|
|
RTI
1650
DELISTED
RTI INTL METALS INC(HLDG CO)
RTI
| $1.19M | ﹤0.01% |
48,264
+10
| +0% | +$270 |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2014 Portfolio in Review
As of Q3 2014, RhumbLine Advisers held 3,039 positions worth $33.3B, down 2.3% from $34.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q3 2014: portfolio turnover was 2.8%. RhumbLine Advisers opened 28 new positions and exited 57, leaving the 3,039-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 346,925 shares worth $12.9M.
- RhumbLine Advisers added most to Allergan plc in Q3 2014, an estimated $29M increase.
- RhumbLine Advisers's biggest Q3 2014 reduction was Apple, cutting an estimated $34.4M.
- RhumbLine Advisers fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $32.2M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $33.3B portfolio in Q3 2014.
- RhumbLine Advisers opened 28 new positions and closed 57 in Q3 2014.
- RhumbLine Advisers's portfolio value fell 2.3% quarter-over-quarter to $33.3B.
Based on RhumbLine Advisers's 13F filing for Q3 2014, filed 12 Nov 2014.